@article{18690,
  keywords = {Adult, Anti-Bacterial Agents, Humans, Hyperpigmentation, Leprosy, lepromatous, Male, Minocycline},
  author = {Fleming C J and Hunt M J and Salisbury E L and McCarthy S W and Barnetson R S},
  title = {Minocycline-induced hyperpigmentation in leprosy.},
  abstract = {<p>A 36-year-old man was treated with dapsone, rifampicin and clofazimine for borderline lepromatous leprosy. After 9 months, his leprosy plaques became progressively more red and after 23 months, the clofazimine was stopped and he was given minocycline instead. Six weeks later, he developed blue-black pigmentation in his leprosy lesions. The histology was consistent with minocycline-induced hyperpigmentation. This is the first report of minocycline-induced pigmentation in leprosy. We suggest it is important to consider this side-effect before the administration of minocycline in leprosy, particularly if it is prescribed in place of clofazimine.</p>},
  year = {1996},
  journal = {The British journal of dermatology},
  volume = {134},
  pages = {784-7},
  month = {1996 Apr},
  issn = {0007-0963},
  language = {eng},
}